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a short 3 UTR, and a poly(A) tail (Figure 1). Insertion
into chromosomal DNA probably occurs by a process
termed target-primed reverse transcription (TPRT); the
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We already know that these elements can alter the
genome in many ways beyond simple insertion of the
element itself. (1) Often 3 and occasionally 5 flankingThe LINE-1 (L1) retrotransposon, the most important
sequences are transduced along with the L1 during ret-human mobile element, shapes the genome in many
rotransposition. The phenomenon of 3 transduction isways. Now two groups provide evidence that L1 retro-
a potential mechanism for shuffling exons from one ge-transposition is associated with large genomic dele-
nomic site to another (Moran et al., 1999). Because 5tions and inversions in transformed cells. If these
truncation frequently limits the retrotransposed se-events occur at a similar frequency in vivo, they have
quence to less than 1 kb, a transduced sequence mayhad a substantial effect on human genome evolution.
include only 3 flanking DNA and completely lack L1
sequences. In addition, because L1 inversion occurs
frequently during retrotransposition, 3 transductionsThe human genome has become an exciting place to
may contain inverted genomic sequence. Thus, trans-visit. Over the past 15 years, our view of it has changed
duction events have considerable potential for scram-considerably, offering a number of surprises and in-
bling retrotransposed sequences and altering the ge-creasing interest in human genetics. In general, the ge-
nome (Figure 1). (2) Although L1 proteins have thenome has great stability; mutation occurs at a rate of
curious property of preferentially acting to retrotrans-109 nucleotides per year. However, there are several
pose the element that encoded them (cis preference),mechanisms that create genome instability. For exam-
they occasionally act in trans to retrotranspose non-L1ple, expanding trinucleotide and other short repeats ac-
RNAs (Esnault et al., 2000; Wei et al., 2001). (3) Mispairingcount for 15–20 diseases (Cummings and Zoghbi, 2000).
of homologous L1 sequences and unequal crossing-We have also learned about long-range rearrangements
over can produce deletions and duplications of genomicthat produce deletions, duplications, and inversions of
sequences. A few cases of human disease have beenup to a few million base pairs. These rearrangements
caused by deletions of this type. (4) L1s contain withinhave caused not only common genomic polymor-
their 5 UTR not only a sense strand promoter for theirphisms, but also 10–15 contiguous gene syndromes in
own transcription, but also an antisense promoter. Thishumans (Emanuel and Shaikh, 2001). In addition, we
antisense Pol II promoter has been shown to providehave discovered that the human genome is even more
an alternative transcription start site for a number ofpopulated with transposable elements than other spe-
human Pol II-transcribed genes (Nigumann et al., 2002).cies whose genomes have been analyzed, and that
In sum, L1s account directly or indirectly for aboutthese “jumping genes” can cause disease and alter the
one-third of the human genome. In fact, non-LTR retro-genome in a number of different ways (reviewed in Os-
transposable elements have been extant since the Pre-tertag and Kazazian, 2001).
cambrian Era 500–600 million years ago. Since se-
There are two main classes of transposable elements:
quences greater than 200 million years old have mutated
DNA transposons and retrotransposons. Retrotranspo-
beyond recognition, it is likely that retrotransposons ac-
sons, the most important transposable elements in the tually account for greater than half and perhaps the bulk
human genome, are copied into RNA, the RNA is re- of the human genome.
verse-transcribed into DNA, and the DNA is inserted Now, two papers in this issue of Cell by Gilbert et al.
into the genome at a new location. Thus, these elements (2002) and Symer et al. (2002) demonstrate that genome
expand in number by a duplication (copy-and-paste) instability, principally in the form of substantial dele-
mechanism. The human genome is littered with rem- tions, is associated with about 10% of L1 insertions in
nants of the most prominent non-long-terminal repeat transformed human cells. New L1 retrotranspositions
(non-LTR) retrotransposon, the L1 element, roughly a have been estimated to occur in vivo at a frequency
half million of which are 5 truncated, inverted, or mu- of one new event in every 10 to 250 individuals born
tated to inactivity. It also contains roughly 5000 full- (reviewed in Ostertag and Kazazian, 2001). If sizable
length 6 kb elements, 60–100 of which are still capable deletions accompany one in every 10 L1 retrotransposi-
of retrotransposition. The full-length elements contain tions in vivo, the effect on genome evolution could be
a 5 untranslated region (5 UTR) with an internal pro- substantial. The finding is also remarkable because ret-
moter, a 1 kb ORF1 that encodes a protein with RNA rotransposition of both non-LTR elements of the L1 type
binding capability, a 4 kb ORF2 that encodes a protein and LTR elements of the yeast Ty variety have been
with endonuclease and reverse transcriptase activities, rarely associated with significant deletions. In contrast,
DNA transposons that generally move by a cut-and-
paste process without using an RNA intermediate (e.g.,1Correspondence: kazazian@mail.med.upenn.edu
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Figure 1. Structure of a Full-Length 6 kb Human L1 Element
Abbreviations: TSD, variable-length target site duplication; 5 UTR, 5 untranslated region; ORF1, first open reading frame; ORF2, second
open reading frame; EN, endonuclease domain; RT, reverse transcriptase domain; 3 UTR, 3 untranslated region; AATAAA, hexanucleotide
poly(A) signal; and An, the poly(A) tract abuts the hexanucleotide signal in humans.
P elements) are known to produce significant deletions 2002). DNA from G418-resistant cultured cells was iso-
lated and cleaved with a restriction enzyme, and theupon leaving a site, and some bacterial transposons
can produce genomic rearrangements upon insertion fragments were self-ligated and transformed into bacte-
rial cells. Thus, L1 integrants together with their flankinginto a new location.
Our present knowledge of the characteristics of L1 genomic DNA were speedily recovered from human cells
as self-replicating bacterial clones selected on eitherretrotranspositions comes from three distinct sources.
One source is insertions into the human genome charac- kanamycin or trimethoprim plates. In this manner, the
authors have significantly increased the number of retro-terized from database searches of the draft human ge-
nome sequence. The most valuable of these insertions transposition events that can be characterized using
this assay (Moran et al., 1996; Esnault et al., 2000; Weiare those of the youngest and most active subfamily of
L1s (the Ta subfamily), which are on average only 2 et al., 2001).
While retrotransposition in cell culture mimics that inmillion years old (Boissinot and Furano, 2001). About
half of these elements are polymorphic as to presence vivo in many respects, there are substantial differences
between the two processes. Retrotransposition in theor absence so that the genomic site that lacks the inser-
tion can be characterized. A second source is the dis- organism likely occurs in both male and female germ
cells and may also occur very early in embryonic devel-ease-causing insertions into the human and mouse ge-
nomes that are very recent (100 years old). To date, opment. There is strong evidence that L1 retrotranspo-
sition is suppressed in somatic cells by mechanisms14 human and 8 mouse de novo insertions are known
(see Ostertag and Kazazian, 2001). The third source is not clearly understood, although promoter repression,
methylation, and RNA interference are among the usualthe new insertions obtained in transformed cells in cul-
ture. Both of the present papers examine cell culture suspects. Although one instance of L1 retrotransposi-
tion has been documented in a colon cancer (Miki etinsertions, while Symer et al. (2002) also compare their
tissue culture data to data obtained from a database al., 1992), it is unclear whether that event occurred in a
transformed cell or a primary epithelial cell. Also, retro-search.
The two papers in this volume employ a time-tested, transposition in vivo occurs from one chromosome to
another. In the tissue culture assay, retrotranspositionplasmid-based strategy for studying individual retro-
transposition events in cultured cells, an approach first events occur from an episome to a chromosomal site in
cells that are transformed and therefore to some extentused by Curcio and Garfinkel (1991) to examine Ty1
insertions in yeast. This assay has been particularly valu- aneuploid and genetically unstable. That said, the new
papers find that L1 insertions in tissue culture are quiteable in studying the biology of L1 retrotransposons
(Moran et al., 1996). A retrotransposon is tagged with a similar to both recent in vivo insertions and database
insertions in many respects, including occurrence ofreporter cassette consisting of an antisense copy of an
auxotrophic or antibiotic resistance gene, interrupted duplications and small deletions at the target site, se-
quence of the endonuclease cleavage site, occurrenceby an intron placed in sense orientation. Transcription
from the retrotransposon’s promoter, splicing of the in- of inversions and 3 transductions, and the presence of
a poly(A) tail.tron, reverse transcription, and insertion of the cDNA
copy of the element into chromatin allows expression As the present papers point out, however, there are
some unusual features of the insertions in tissue culture.of the reporter gene. Transcipts generated from the pro-
moter of the marker gene prior to retrotransposition fail Although only about 1% of the L1s of all ages in the
genome are full-length, some 30%–35% of the youngto be expressed because the disrupting intron cannot
be spliced due to its orientation. Such strategies capture Ta subfamily of elements is full-length (Boissinot and
Furano, 2001). Among recent insertions, 2 of 14 in hu-retrotransposition events red-handed, before inserted
sequences are blurred by time and the genomic forces mans and 3 of 8 in mice are full-length, or 5/22 (23%)
in all. Thus, one might expect that a substantial fractionof mutation, recombination, and gene conversion.
The authors of the present papers use the mneoI re- of insertions would be full-length when a Ta element is
used in the cultured cell assay. Combining the data fromporter cassette that confers G418 resistance upon cells
acquiring an L1 insertion. Taking a cue from “self-clon- the two papers yields 8 insertions of 6 kb or longer
among 75 insertions, or 10%. Likewise in the genome,ing” or “plasposon” strategies that have facilitated re-
covery of bacterial transposon integrants (reviewed in nearly all target site duplications (TSDs) are 20 bp or
shorter, whereas 10 of 28 TSDs in Gilbert et al. (2002)Dennis and Zylstra, 1998), the authors cleverly reengin-
eered mneoI to contain a bacterial origin of replication, and 3 of 33 TSDs in Symer et al. (2002) are longer than
30 bp. In addition, Symer and colleagues found thatShine-Dalgarno sequence, and a bacterial promoter up-
stream of either the neoR gene (Gilbert et al., 2002) or 50% of their L1 insertions interrupted predicted genes,
a bias not detected by other studies in HeLa cells (Morana separate dihydrofolate reductase gene (Symer et al.,
Minireview
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Figure 2. L1 Elements Alter Mammalian Ge-
nomes in Many Ways upon Retrotranspo-
sition
(1) L1 proteins tend to act in cis on their own
encoding RNA to generate new retrotranspo-
sition events. Newly inserted copies may be
full-length (A) and potentially active. How-
ever, more frequently they have 5 truncations
(B) or 5 truncations and inversions (C) and
are incapable of further retrotransposition.
(2) Occasionally L1 proteins act in trans to
mobilize non-L1 RNAs. L1s have likely been
responsible for the genome-wide dispersal of
processed pseudogenes (roughly 1% of the
genome) and of Alu nonautonomous retro-
transposons (numbering 1.1 million copies or
10% of the human genome). A processed
pseudogene forms when a spliced mRNA is
reverse transcribed by L1 reverse tran-
scriptase and the resulting DNA is inserted
into the genome.
(3) Rarely, L1s are able to integrate into pre-
formed double-strand breaks generated in-
dependently of the L1 endonuclease. The in-
tegrant structures are atypical, being
truncated at their 3 ends, and they lack TSDs.
(4) L1s are able to mobilize both 3 and, less
commonly, 5 flanking DNA upon retrotrans-
position and carry these flanks to new geno-
mic locations. (A) In the case of 3 transduc-
tion, the weak L1 polyadenylation signal is
occasionally bypassed by the RNA 3 pro-
cessing machinery in favor of a second down-
stream polyadenylation signal. (B) Sequence
5 of an L1 may be transduced if (1) the L1
promoter initiates transcription at an abnor-
mal upstream site, or (2) if the chance pres-
ence of a non-L1 upstream promoter gener-
ates an elongated L1 transcript. Thus, L1s
may play a role in “exon shuffling.” An L1
residing in the intron of a gene might trans-
duce upstream or downstream exonic sequence to a new site, possibly into another gene.
(5) Two papers in this issue of Cell report large-scale deletions (A) and inversions (B) at the site of L1 insertions generated in a cell culture
assay. The inserted L1s associated with these chromosomal rearrangements lack TSDs but may have a poly(A) tail. Note that the second
junction of the inversion in (B) was not detected by Symer et al. (2002), so that whether the inversion involved a deletion or other rearrangement
is unknown. Other genomic effects of L1s, such as recombination between mispaired L1s producing deletions or duplications and alternative
transcription of some Pol II-dependent genes from a promoter within L1, are not shown here.
et al., 1999; Gilbert et al., 2002) or in the draft human in the organism? One test for deletions upon retrotrans-
position would be to find empty sites (sites into whichgenome sequence.
The most unusual feature of the insertions in tissue an L1 insertion has occurred) that contain more genomic
DNA than do those sites after L1 insertion. In otherculture is the 7 large deletions and 1 potential chromo-
somal inversion observed among 79 insertions, an inci- words, if one studies polymorphic young L1 elements
in the human genome, are the empty sites larger thandence of genomic rearrangements of 10%. One simple
explanation for these rearrangements, which cannot be expected? Myers et al. (2002) were able to characterize
the empty site for 115 polymorphic L1s from the Taruled out by the cell culture data, is that RNA has pro-
vided a template used to patch double-stranded and subfamily and found no evidence for deletions among
them. However, the empty sites of five other polymor-degraded DNA breaks within cells hosting the L1 inser-
tions. Insertion of both L1 and Ty1 elements at breaks phic elements “produced nonspecific PCR results” and
were excluded from the analysis. The failure to amplifygenerated independently of the element-encoded endo-
nucleases has been demonstrated in cell culture (Teng these empty sites could be due to deletions accompa-
nying retrotransposition, repetitive DNA at the emptyet al., 1996; Morrish et al., 2002). However, unlike the
L1 endonuclease-independent events characterized to sites, or assembly errors in the draft human genome
sequence. Our laboratory has analyzed 25 polymorphicdate (Morrish et al., 2002), four of the seven L1s reported
in the present studies both possess a poly(A) tail and full-length Ta elements that do not overlap with those of
Myers et al. (2002) and found empty sites of the expectedhave inserted at a consensus L1 target site, suggesting
that their associated rearrangements were mediated by size for all of them. Thus, these data would suggest
that the frequency of DNA deletions created upon L1retrotransposition.
To what extent can such rearrangements be observed retrotransposition is at most 5/145 or 3%.
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Moran, J.V., DeBerardinis, R.J., and Kazazian, H.H., Jr. (1999). Sci-However, some genomic deletions between 3 and 70
ence 283, 1530–1534.kb observed by Gilbert et al. (2002) and Symer et al.
Morrish, T.A., Gilbert, N., Myers, J.S., Vincent, B.J., Stamato, T.D.,(2002) might be deleterious to the organism and elimi-
Taccioli, G.E., Batzer, M.A., and Moran, J.V. (2002). Nat. Genet. 31,nated from the genome. Even the youngest of the poly-
159–165.
morphic Ta subfamily L1s in the draft human genome
Myers, J.S., Vincent, B.J., Udall, H., Watkins, W.S., Morrish, T.A.,
sequence must be thousands of years old. Thus, it is Kilroy, G.E., Swergold, G.D., Henke, J., Henke, L., Moran, J.V., et al.
potentially more instructive to analyze insertions that (2002). Am. J. Hum. Genet. 71, 312–326.
have occurred into mammalian genomes in the past Nigumann, P., Redik, K., Matlik, K., and Speek, M. (2002). Genomics
100 years. No deletions have been found among the 14 79, 628–634.
known recent L1 insertions in humans. Among eight Ostertag, E.M., and Kazazian, H.H., Jr. (2001). Annu. Rev. Genet.
known recent L1 insertions in the mouse, six are straight- 35, 501–538.
forward endonuclease-dependent events, one appears Symer, D.E., Connelly, C., Szak, S.T., Caputo, E.M., Cost, G.J., Par-
migiani, G., and Boeke, J.D. (2002). Cell 110, this issue, 327–338.to be an endonuclease-independent event associated
with a deletion in the disabled-1 gene (Kojima et al., Teng, S.C., Kim, B., and Gabriel, A. (1996). Nature 383, 641–644.
2000), and one may well be an endonuclease-dependent Wei, W., Gilbert, N., Ooi, S.L., Lawler, J.F., Ostertag, E.M., Kazazian,
H.H., Boeke, J.D., and Moran, J.V. (2001). Mol. Cell. Biol. 21, 1429–L1 retrotransposition associated with a deletion (Garvey
1439.et al., 2002). In this latter event, a 5 truncated L1 derived
from a subfamily of active mouse L1s is associated with
a 779 bp deletion of the titin gene in the mdm mouse.
Thus, the recent insertion data suggest a 5% incidence
of endonuclease-mediated deletions associated with re-
cent L1 insertions (1/22) and, together with the data
from polymorphic Ta L1s, are in line with the cell culture
data of the present papers (4/79 L1 insertions as-
sociated with endonuclease-mediated rearrangement
events, or 5%).
In order to determine the frequency of in vivo genomic
rearrangements occurring during retrotransposition, we
need a mouse model of retrotransposition. We now
know that such a mouse model is feasible, and that
retrotransposition events produced by a human L1
transgene are stably inherited. After characterizing a
large number of retrotransposition events that have oc-
curred in the germline of transgenic mice, we should
learn the degree to which L1s sculpt genomic DNA. In
the meantime, the Moran and Boeke labs provide us with
more tantalizing evidence for L1s as genome artisans.
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